CASE REPORT
Accidentally detected nephrocalcinosis in a boy with a homozygous R396W mutation in the CYP24A1 gene – 7-year follow-up
1
Department of Pediatrics, Neonatal Pathology and Metabolic Bone Diseases, Medical University of Lodz, Lodz, Poland
2
Department of Pediatrics, Diabetology, Endocrinology and Nephrology, Medical University of Lodz, Lodz, Poland
3
Department of Pediatrics, University of Zielona Gora, Zielona Gora, Poland
Submission date: 2023-03-01
Final revision date: 2023-05-29
Acceptance date: 2023-06-03
Publication date: 2023-12-15
Corresponding author
Jakub Krzysztof Nowicki
Jakub Krzysztof Nowicki, Department of Pediatrics, Neonatal Pathology and Metabolic Bone Diseases, Medical University of Lodz, Sporna 36/50, 91-738 Lodz, Poland
Jakub Krzysztof Nowicki, Department of Pediatrics, Neonatal Pathology and Metabolic Bone Diseases, Medical University of Lodz, Sporna 36/50, 91-738 Lodz, Poland
Pediatr Pol 2023;98(4):351-361
KEYWORDS
TOPICS
ABSTRACT
Nephrocalcinosis can manifest as frequent urination, haematuria and recurrent urinary tract infections, as well as a decrease in bone mineral density, increasing the risk of osteoporosis. Excessive urinary calcium excretion may have a genetic basis, including mutations within the genes encoding vitamin D3 metabolising enzymes. This paper presents a report of a 7-year follow-up of a boy in whom abdominal ultrasound incidentally detected nephrocalcinosis. The patient was confirmed to have a homozygous R396W mutation in the CYP24A1 gene, which encodes an enzyme responsible for inactivating calcitriol and protecting the cell from vitamin D3 intoxication. Radiological examinations showed a decrease in bone mineral density in the spine. Genetic factors, especially those related to abnormal vitamin D3 metabolism, should be considered in the differential diagnosis of incidentally detected nephrocalcinosis. Children with excessive urinary calcium excretion are at particular risk of developing skeletal complications, including osteopenia and osteoporosis.
REFERENCES (16)
1.
Vervaet BA, Verhulst A, D’Haese PC, et al. Nephrocalcinosis: new insights into mechanisms and consequences. Nephrol Dial Transplant 2009; 24: 2030-2035.
2.
Habbig S, Beck BB, Hoppe B. Nephrocalcinosis and urolithiasis in children. Kidney Int 2011; 80: 1278-1291.
3.
Srivastava T, Schwaderer A. Diagnosis and management of hypercalciuria in children. Curr Opin Pediatr 2009; 21: 214-219.
4.
Zerwekh JE. Bone disease and hypercalciuria in children. Pediatr Nephrol 2010; 25: 395-401.
5.
Jones G, Prosser DE, Kaufmann M. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys 2012; 523: 9-18.
6.
Carpenter TO. CYP24A1 loss of function: clinical phenotype of monoallelic and biallelic mutations. J Steroid Biochem Mol Biol 2017; 173: 337-340.
7.
Kamińska A, Sołtyski J, Roszkowska-Blaim M, et al. Przydatność testu Paka w modyfikacji Stapletona w diagnostyce hiperkalciurii u dzieci. Pol Merk Lek 2008; 24 (Supl. 4): 38.
8.
Dusso AS, Brown AJ, Slatopolsky E, et al. Vitamin D. Am J Physiol Renal Physiol 2005; 289: 8-28.
9.
DeLuca HF. Vitamin D: Metabolism and Function. Monographs on Endocrinology. Springer, Berlin, Heidelberg, New York 1979; 13: 1-80.
10.
Jacquillet G, Unwin RJ. Physiological regulation of phosphate by vitamin D, parathyroid hormone (PTH) and phosphate (Pi). Pflugers Arch 2019; 471: 83-98.
11.
Schlingmann KP, Kaufmann M, Weber S, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 2011; 365: 410-421.
12.
Pronicka E, Ciara E, Halat P, et al. Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases. J Appl Genet 2017; 58: 349-353.
13.
Dowen FE, Sayers JA, Hynes AM, et al. CYP24A1 mutation leading to nephrocalcinosis. Kidney Int 2014; 85: 1475.
14.
Aladjem M, Barr J, Lahat E, et al. Renal and absorptive hypercalciuria: a metabolic disturbance with varying and interchanging modes of expression. Pediatrics 1996; 97: 216-219.
15.
Sayers J, Hynes AM, Srivastava S, et al. Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole. Clin Kidney J 2015; 8: 453-455.
16.
Ward LM, Weber DR, Munns CF, et al. A contemporary view of the definition and diagnosis of osteoporosis in children and adolescents. J Clin Endocrinol Metab 2020; 105: 2088-2097.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
